Clinical Reasoning: A 47-year-old man with diffuse white matter disease and rapidly progressive dementia

Neurology. 2019 Jun 11;92(24):e2832-e2837. doi: 10.1212/WNL.0000000000007655.

Authors

Daniel G Di Luca¹, Jonathan Landman², Melissa R Ortega², Sakir Humayun Gultekin², Xiaoyan Sun²

Affiliations

¹ From the Department of Neurology (D.G.D.L., J.L., M.R.O., X.S.); Evelyn F, McKnight Brain Institute (X.S.); Brain Endowment Bank (S.H.G., X.S.); and Department of Pathology (S.H.G.), University of Miami Miller School of Medicine, FL. Daniel.garbindiluc@jhsmiami.org.
² From the Department of Neurology (D.G.D.L., J.L., M.R.O., X.S.); Evelyn F, McKnight Brain Institute (X.S.); Brain Endowment Bank (S.H.G., X.S.); and Department of Pathology (S.H.G.), University of Miami Miller School of Medicine, FL.

PMID: 31182521
DOI: 10.1212/WNL.0000000000007655

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies / immunology
Autoimmune Diseases of the Nervous System / diagnosis*
Autoimmune Diseases of the Nervous System / drug therapy
Autoimmune Diseases of the Nervous System / immunology
Autoimmune Diseases of the Nervous System / psychology
Calcium Channels / immunology
Dementia / diagnosis*
Dementia / drug therapy
Dementia / immunology
Dementia / psychology
Disease Progression
Glucocorticoids / therapeutic use
Humans
Leukoencephalopathies / diagnosis*
Leukoencephalopathies / drug therapy
Leukoencephalopathies / immunology
Leukoencephalopathies / psychology
Male
Methylprednisolone / therapeutic use
Middle Aged

Substances

Autoantibodies
Calcium Channels
Glucocorticoids
Methylprednisolone